Is there a circadian variation in 5-Fluorouracil (5FU) plasma concentration (Cp) given by continuous infusion?

被引：0
|
作者：
Strocchi, E
Camaggi, CM
Martoni, A
Sereni, A
Pannuti, R
Pittureri, C
Cacciari, N
Zamagni, C
Pannuti, F
机构：
[1] ANT Lab, Dept Organ Chem, Bologna, Italy
[2] S Orsola M Malpighi Hosp, Div Med Oncol, Bologna, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
243P
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [31] REGIONAL CHEMOTHERAPY TO THE CANINE LIVER WITH 5-FLUOROURACIL (5FU) AND ADRIAMYCIN (AM)
    KARAKOUSIS, CP
    SHARMA, SD
    KANTER, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 211 - 211
  • [32] SEQUENTIAL METHOTREXATE (MTX) AND 5-FLUOROURACIL (5FU) IN ADENOCARCINOMA OF THE COLON AND RECTUM
    DRAPKIN, R
    GRIFFITHS, E
    MCALOON, E
    PALADINE, W
    SOKOL, G
    LYMAN, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 453 - 453
  • [33] INHIBITION OF ACONITASE (AC) ACTIVITY BY 5-FLUOROURACIL (5FU) AND METABOLITES IN THE RAT
    HUTSON, PR
    GRALINSKI, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (02) : 144 - 144
  • [34] Effect of vehicles on topical delivery of 5-fluorouracil (5FU) by 1-acyl-5FU prodrugs
    Patrick, AI
    Beall, HD
    Gilroy, P
    Sloan, KB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 154 (01) : 39 - 48
  • [35] MODIFIED 5-FLUOROURACIL (5FU)+ CISPLATINUM (CP) REGIMEN IN ADVANCED SQUAMOUS HEAD AND NECK-CANCER (HNC)
    KRASNOW, SH
    WADLEIGH, RG
    ANDERSON, AJ
    WHITE, KS
    COHEN, MH
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 216 - 216
  • [36] Continuous infusion fluorouracil (5FU) in heavily pre-treated mCRPC patients.
    Manogue, Charlotte
    Moses, Marcus Marie
    Lewis, Brian E.
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [37] Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion
    Gini F Fleming
    Philip Schumm
    Greg Friberg
    Mark J Ratain
    Uchenna O Njiaju
    Richard L Schilsky
    BMC Cancer, 15
  • [38] Circadian variation in plasma 5-fluorouracil concentrations during a 24 hour constant-rate infusion
    Fleming, Gini F.
    Schumm, Philip
    Friberg, Greg
    Ratain, Mark J.
    Njiaju, Uchenna O.
    Schilsky, Richard L.
    BMC CANCER, 2015, 15
  • [39] Cardiotoxicity and 5-fluorouracil (5 FU) continuous infusion (c.i.): A mono institutional experience
    Gallucci, G.
    Capobianco, A.
    Bochicchio, A. M.
    Coccaro, M.
    Ardito, R.
    Di Leo, P.
    Romano, G.
    Tartarone, A.
    Musto, C.
    Faruolo, M.
    di Renzo, N.
    ANNALS OF ONCOLOGY, 2005, 16 : 37 - 37
  • [40] PLASMA-LEVELS OF THYMIDINE (TDR) PHOSPHORYLASE (TP) DURING TDR AND 5-FLUOROURACIL (5FU) THERAPY
    SALSER, JS
    BALIS, ME
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 127 - 127
12345